Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Cefixime - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefixime and what is the scope of cefixime freedom to operate?

Cefixime
is the generic ingredient in two branded drugs marketed by Lederle, Lupin Pharms, Aurobindo Pharma Ltd, Belcher Pharms Llc, and Lupin Ltd, and is included in eleven NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Cefixime has two patent family members in two countries.

There are fourteen drug master file entries for cefixime. Eight suppliers are listed for this compound.

Summary for Generic Name: cefixime

Tradenames:2
Patents:2
Applicants:5
NDAs:11
Drug Master File Entries: see list14
Suppliers / Packagers: see list8
Bulk Api Vendors: see list43
Clinical Trials: see list5
Patent Applications: see list7,071
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cefixime at DailyMed

Pharmacology for Ingredient: cefixime

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
SUPRAX
cefixime
TABLET, CHEWABLE;ORAL065380-002Oct 25, 2010RXNoNo► Subscribe► Subscribe
Lupin Pharms
SUPRAX
cefixime
TABLET;ORAL065130-001Feb 12, 2004RXNoYes► Subscribe► Subscribe
Lupin Ltd
SUPRAX
cefixime
FOR SUSPENSION;ORAL202091-001Feb 20, 2013ABRXYesYes9,233,112► SubscribeY ► Subscribe
Lederle
SUPRAX
cefixime
FOR SUSPENSION;ORAL050622-001Apr 28, 1989DISCNYesNo► Subscribe► Subscribe
Lupin Ltd
SUPRAX
cefixime
CAPSULE;ORAL203195-001Jun 1, 2012RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot